Back to mobile site

Incyte's (INCY) OPZELURA Launch in Line with Expectations - Mizuho

January 18, 2022 5:56 AM EST Send to a Friend
Mizuho Securities analyst Mara Goldstein reiterated a Neutral rating and $95.00 price target on Incyte (NASDAQ: INCY), following a recent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login